Euromedis Groupe (ALEMG.PA)
EUR 3.58
(2.27%)
EUR 3.58
(2.27%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 5.08 Million EUR | -60.37% |
| 2022 | 12.83 Million EUR | -14.36% |
| 2021 | 14.98 Million EUR | -8.93% |
| 2020 | 16.45 Million EUR | 90.6% |
| 2019 | 8.63 Million EUR | 452.82% |
| 2018 | 1.56 Million EUR | -17.31% |
| 2017 | 1.88 Million EUR | 6.84% |
| 2016 | 1.76 Million EUR | -23.16% |
| 2015 | 2.3 Million EUR | 11.75% |
| 2014 | 2.05 Million EUR | -14.99% |
| 2013 | 2.42 Million EUR | 0.17% |
| 2012 | 2.41 Million EUR | -30.26% |
| 2011 | 3.46 Million EUR | -2.97% |
| 2010 | 3.57 Million EUR | 0.0% |
| 2009 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 9.03 Million EUR | 0.0% |
| 2023 Q4 | 5.08 Million EUR | 0.0% |
| 2023 Q3 | 5.08 Million EUR | -56.88% |
| 2023 Q2 | 11.79 Million EUR | 0.05% |
| 2023 Q1 | 11.78 Million EUR | -8.16% |
| 2023 FY | 5.08 Million EUR | -60.37% |
| 2022 FY | 12.83 Million EUR | -14.36% |
| 2022 Q3 | 12.83 Million EUR | 20273.02% |
| 2022 Q2 | 63 Thousand EUR | -99.55% |
| 2022 Q1 | 13.94 Million EUR | -6.93% |
| 2022 Q4 | 12.83 Million EUR | 0.0% |
| 2021 Q1 | 118 Thousand EUR | -99.28% |
| 2021 FY | 14.98 Million EUR | -8.93% |
| 2021 Q3 | 14.99 Million EUR | -6.73% |
| 2021 Q2 | 16.07 Million EUR | 13520.34% |
| 2021 Q4 | 14.98 Million EUR | -0.01% |
| 2020 Q3 | 16.45 Million EUR | -1.56% |
| 2020 Q1 | 16.65 Million EUR | 92.82% |
| 2020 FY | 16.45 Million EUR | 90.6% |
| 2020 Q2 | 16.71 Million EUR | 0.41% |
| 2020 Q4 | 16.45 Million EUR | 0.0% |
| 2019 Q2 | 3.71 Million EUR | 0.0% |
| 2019 Q4 | 8.63 Million EUR | 21.43% |
| 2019 Q3 | 7.11 Million EUR | 91.21% |
| 2019 FY | 8.63 Million EUR | 452.82% |
| 2019 Q1 | 3.71 Million EUR | 0.0% |
| 2018 FY | 1.56 Million EUR | -17.31% |
| 2017 Q1 | 1.88 Million EUR | 11.64% |
| 2017 FY | 1.88 Million EUR | 6.84% |
| 2017 Q4 | 1.76 Million EUR | 0.0% |
| 2017 Q3 | 1.76 Million EUR | -6.67% |
| 2017 Q2 | 1.88 Million EUR | 0.0% |
| 2016 FY | 1.76 Million EUR | -23.16% |
| 2016 Q4 | 1.69 Million EUR | 0.0% |
| 2016 Q1 | 1.76 Million EUR | -12.86% |
| 2016 Q2 | 1.76 Million EUR | 0.0% |
| 2016 Q3 | 1.69 Million EUR | -4.3% |
| 2015 FY | 2.3 Million EUR | 11.75% |
| 2015 Q2 | 2.3 Million EUR | 0.0% |
| 2015 Q1 | 2.3 Million EUR | -1.96% |
| 2015 Q4 | 2.02 Million EUR | 0.0% |
| 2015 Q3 | 2.02 Million EUR | -11.82% |
| 2014 Q4 | 2.34 Million EUR | 0.0% |
| 2014 FY | 2.05 Million EUR | -14.99% |
| 2014 Q2 | 2.05 Million EUR | 2.8% |
| 2014 Q1 | 2 Million EUR | -1.23% |
| 2014 Q3 | 2.34 Million EUR | 13.99% |
| 2013 Q2 | 2.42 Million EUR | 0.0% |
| 2013 Q3 | 2.02 Million EUR | -16.27% |
| 2013 Q4 | 2.02 Million EUR | 0.0% |
| 2013 Q1 | 2.42 Million EUR | 14.95% |
| 2013 FY | 2.42 Million EUR | 0.17% |
| 2012 Q1 | 2.41 Million EUR | 100.66% |
| 2012 Q4 | 2.1 Million EUR | 0.0% |
| 2012 Q3 | 2.1 Million EUR | -12.86% |
| 2012 Q2 | 2.41 Million EUR | 0.0% |
| 2012 FY | 2.41 Million EUR | -30.26% |
| 2011 Q3 | 1.2 Million EUR | -65.24% |
| 2011 FY | 3.46 Million EUR | -2.97% |
| 2011 Q4 | 1.2 Million EUR | 0.0% |
| 2011 Q2 | 3.46 Million EUR | 0.0% |
| 2010 Q2 | 3.57 Million EUR | 0.0% |
| 2010 Q4 | 2.34 Million EUR | 0.0% |
| 2010 FY | 3.57 Million EUR | 0.0% |
| 2009 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Affluent Medical SA | 14.41 Million EUR | 64.707% |
| Bluelinea Société Anonyme | 2.11 Million EUR | -140.971% |
| Carmat SA | 57.64 Million EUR | 91.178% |
| Diagnostic Medical Systems S.A. | 13.19 Million EUR | 61.463% |
| Eurobio Scientific Société anonyme | 81.23 Million EUR | 93.739% |
| Ikonisys S.A. | 3.2 Million EUR | -58.568% |
| Implanet S.A. | 1.38 Million EUR | -268.023% |
| Median Technologies SA | 21.64 Million EUR | 76.497% |
| SpineGuard SA | 1.87 Million EUR | -171.163% |
| Theraclion SA | 1.95 Million EUR | -160.726% |
| Euroapi S.A. | 15.5 Million EUR | 67.187% |
| Guerbet SA | 360.51 Million EUR | 98.589% |